Planisware Hosts the 2008 Annual Pharmaceutical User Group Conference with Record Attendance

Share Article

Over 100 attendees from 30 Pharma Companies meet for two days in Manhattan

Planisware today announced record attendance at its Annual Pharmaceutical User Group Conference held in New York City on May 19-20. Planisware hosted 100 attendees representing 30 international Fortune 500 companies all of whom are leaders within the Pharmaceutical Industry.

Numerous industry leaders presented on topics ranging from Resource and Capacity Management to the Importance of using Planisware's Integrated PPM tool to manage New Product Development and Innovation. Planisware also facilitated a number of Round Table Discussions around best practices in Project Management, Portfolio Management, Reporting, Scheduling, Resource Management and Cost Management.

"Planisware's Pharmaceutical User Group Conference is an annual event that brings industry leaders together to discuss, present and learn about best practices in Drug Development, Project Management, and Portfolio Management. After 7 years of hosting this meeting, it is gratifying to not only witness the continued growth in the number of participants, but more importantly to see all of these companies share how Product Portfolio Management with Planisware has directly benefited their organizations, increased their new product throughput, and maximized their R&D investment." said Pierre Demonsant, CEO of Planisware.

The companies represented at the conference included Alcon Labs, Medimmune, Amgen, Merck & Co., AstraZeneca ,Merck Serono, Biogen Idec ,Novartis, Biomerieux ,Novo Nordisk, Bristol-Myers Squibb, PDL BioPharma, Chiesi , Pharmica Consulting, Duke Clinical Research, PWC, ePharmaSolutions , Sanofi Aventis, Figel Technologies, Genentech, Servier, GSK Pharma, Solvay, IPM, Inc, Syngeta, Johnson & Johnson BIO, UCB Group, Johnson & Johnson PRD, and Wyeth.

About Planisware:
Planisware is the leading global Product Portfolio Management software company supplying real solutions to companies managing complex R&D investments. The acclaimed flexibility of the Planisware solution allows customers to align the software solution with key business programs and portfolio management processes. Planisware is a profitable, growing, global company with 30% annual growth, 150,000 users and over 100 Global 1000 companies as customers. To learn more about Planisware, visit, call 888-752-6479 or info @


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Paul Granese
Visit website